Eli Lilly Predicts Medicare Coverage Of Zepbound Will Draw Current DTC Customers

Medicare coverage was a long-sought opportunity for obesity drugs. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers